Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680

MLA

Schindler, Charles W., et al. “Lack of Adenosine A1 and Dopamine D2 Receptor-Mediated Modulation of the Cardiovascular Effects of the Adenosine A2A Receptor Agonist CGS 21680.” European Journal of Pharmacology, vol. 484, no. 2/3, Jan. 2004, p. 269. EBSCOhost, https://doi.org/10.1016/j.ejphar.2003.11.010.

APA

Schindler, C. W., Karcz-Kubicha, M., Thorndike, E. B., Müller, C. E., Tella, S. R., Goldberg, S. R., & Ferré, S. (2004). Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680. European Journal of Pharmacology, 484(2/3), 269. https://doi.org/10.1016/j.ejphar.2003.11.010

Chicago

Schindler, Charles W., Marzena Karcz-Kubicha, Eric B. Thorndike, Christa E. Müller, Srihari R. Tella, Steven R. Goldberg, and Sergi Ferré. 2004. “Lack of Adenosine A1 and Dopamine D2 Receptor-Mediated Modulation of the Cardiovascular Effects of the Adenosine A2A Receptor Agonist CGS 21680.” European Journal of Pharmacology 484 (2/3): 269. doi:10.1016/j.ejphar.2003.11.010.